OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 8
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 8
Showing 8 citing articles:
A stumbling block in pancreatic cancer treatment: drug resistance signaling networks
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Jinming Liu, Biao Zhang, Bingqian Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 1
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Targeting PI3K Signaling to Overcome Tumor Immunosuppression: Synergistic Strategies to Enhance Cancer Vaccine Efficacy
Ran Cui, Zhongqin Luo, Xialin Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 292-292
Open Access | Times Cited: 1
Ran Cui, Zhongqin Luo, Xialin Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 292-292
Open Access | Times Cited: 1
Overcoming drug resistance in ovarian cancer through PI3K/AKT signaling inhibitors
Madhunika Agrawal, Satyam Kumar Agrawal, Kanwaljit Chopra
Gene (2025), pp. 149352-149352
Closed Access
Madhunika Agrawal, Satyam Kumar Agrawal, Kanwaljit Chopra
Gene (2025), pp. 149352-149352
Closed Access
A Comprehensive Review of Nanoparticle-Based Drug Delivery for Modulating PI3K/AKT/mTOR-Mediated Autophagy in Cancer
Md. Ataur Rahman, Maroua Jalouli, Sujay Kumar Bhajan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1868-1868
Open Access
Md. Ataur Rahman, Maroua Jalouli, Sujay Kumar Bhajan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1868-1868
Open Access
Characterization of lncRNAs contributing to drug resistance in epithelial ovarian cancer
Ehteram Khademi Siahestalkhi, Aydın Demiray, Arzu Yaren, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Open Access
Ehteram Khademi Siahestalkhi, Aydın Demiray, Arzu Yaren, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Open Access
Study on drug-mediated protein–protein interaction in single living cells by fluorescence cross-correlation spectroscopy
Wei Zhang, Xinwei Lu, Jicun Ren
The Analyst (2025)
Closed Access
Wei Zhang, Xinwei Lu, Jicun Ren
The Analyst (2025)
Closed Access
Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of progression, resistance, and emerging therapeutic strategies
Michelle van der Merwe, Kathryn H. Myburgh, Cathie Garnis, et al.
Gene (2025), pp. 149467-149467
Open Access
Michelle van der Merwe, Kathryn H. Myburgh, Cathie Garnis, et al.
Gene (2025), pp. 149467-149467
Open Access
Exploring the Redox and pH Dimension of Carbonic Anhydrases in Cancer: A Focus on Carbonic Anhydrase 3
Yezhou Yu, Sally‐Ann Poulsen, Giovanna Di Trapani, et al.
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 13-15, pp. 957-975
Closed Access | Times Cited: 2
Yezhou Yu, Sally‐Ann Poulsen, Giovanna Di Trapani, et al.
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 13-15, pp. 957-975
Closed Access | Times Cited: 2
Design, Synthesis, and Pharmacological Evaluation of Triazine-based PI3K/mTOR Inhibitors for the Potential Treatment of Non-Small Cell Lung Cancer
Ming Zeng, Ying-xuan Hu, Lan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117200-117200
Closed Access | Times Cited: 1
Ming Zeng, Ying-xuan Hu, Lan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117200-117200
Closed Access | Times Cited: 1
